Try our mobile app

General information

Country: UNITED STATES

Sector: Diagnostics and Research

Thermo Fisher Scientific, Inc. manufactures scientific instruments, consumables, and chemicals. The Company offers analytical instruments, laboratory equipment, software, services, consumables, reagents, chemicals, and supplies to pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies.
Website: thermofisher.com


  • Pretty weak financial results growth rate 1.2% (average between last period year over year growth for revenue and EBITDA), there is acceleration compared to average historical growth rates (-0.7%)
  • Dividend yield for the last twelve months 0.4%
  • Free cash flow yield -0.7% (LTM)
  • Share price is 21.4% higher than minimum and 24.1% lower than maximum for the last 3 years
  • The company is undervalued by EV / LTM EBITDA multiple compared to target level (19.2x vs
    )
  • Fundamental value created in LTM (estimate)
  • For the last 3 months insiders sold company shares on $14.0 mln (-0.008% of cap.)

Key Financials (Download financials)

Ticker: TMO
Share price, USD:  (-0.2%)473.91
year average price 495.96  


year start price 611.88 2024-09-24

max close price 619.33 2024-09-26

min close price 390.26 2025-06-17

current price 473.90 2025-09-23
Common stocks: 391 000 000

Dividend Yield:  0.4%
FCF Yield LTM: -0.7%
EV / LTM EBITDA: 19.2x
EV / EBITDA annualized: 22.6x
Last revenue growth (y/y):  +0.2%
Last growth of EBITDA (y/y):  +2.3%
Historical revenue growth:  +1.8%
Historical growth of EBITDA:  -3.2%
Target EV / EBITDA (hist percentile):
Express share price potential:
Fundamental value created in LTM:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 185 299
Net Debt ($m): -5 849
EV (Enterprise Value): 179 450
EBITDA LTM ($m): 9 369
EV / LTM EBITDA: 19.2x
Price to Book: 3.8x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2025-09-17globenewswire.com

Thirty Inspiring Middle School Scientists and Engineers Shine as Finalists in the Thermo Fisher Scientific Junior Innovators Challenge

2025-09-05seekingalpha.com

Thermo Fisher Scientific Inc. (TMO) J.P. Morgan CEO Call Series Call (Transcript)

2025-08-28zacks.com

Should You Continue to Hold Thermo Fisher Stock in Your Portfolio?

2025-08-28businesswire.com

Thermo Fisher Scientific Secures R&D 100 Awards for Innovations Accelerating the Discovery and Development of Therapies

2025-08-22zacks.com

Thermo Fisher (TMO) Up 1.8% Since Last Earnings Report: Can It Continue?

2025-08-19benzinga.com

Thermo Fisher Positioned As Biopharma's Partner Of Choice

2025-08-15zacks.com

TMO Receives FDA Approval for Oncomine Dx Target Test

2025-08-11seekingalpha.com

Thermo Fisher: Growth Acceleration And Margin Expansion Should Drive The Upside

2025-08-06seekingalpha.com

Thermo Fisher Q2: Pharma And Biotech Gains Offset By Weak Academic And Gov't Markets

2025-08-04zacks.com

Investing in Thermo Fisher (TMO)? Don't Miss Assessing Its International Revenue Trends
More information for subscribed users:
detailed calculation of
Potential and Created Value,
website traffic data